NMD Pharma
Company Presentation
Company Presentation
Company Presentation
Annual Report 2018 by Lundbeckfonden - issuu
Rare Neuromuscular Disease Company NMD Pharma Raises USD 3 Million in Seed Financing Round - Lundbeckfonden
Management — NMD Pharma
Redalyc.Endocrine disruptors: strategies for determination and occurrence in marine environments
Management — NMD Pharma
PDF) CIC-1 chloride channels: State-of-the-art research and future challenges
Thomas Holm Pedersen - Chief Executive Officer, Associate professor of Physiology and Biophysics in Aarhus, Arhus, Denmark | eMedEvents
Management — NMD Pharma
65% 460 175+ 150+
NMD Pharma
Company Presentation
Thomas Holm Pedersen - Crunchbase Person Profile
Annual Report 2017 by Lundbeckfonden - issuu
PDF) Perceptions of gender equity in departmental leadership, research opportunities, and clinical work attitudes: an international survey of 11 781 anaesthesiologists
Company Presentation
Management — NMD Pharma
Management — NMD Pharma
Management — NMD Pharma
Company Presentation
Denmark in New York on Twitter: "#DKBIO17 is "a great opportunity for us to broaden our scope and look for investors.” - Thomas H. Pedersen, CEO, NMD Pharma… https://t.co/AUeO5JqgX6"
Management — NMD Pharma
Annual Report 2019 by Lundbeckfonden - issuu
